MedPath

Effects of alendronate and denosumab on glucocorticoid-induced osteoporosis by a randomized, open-labeled study

Not Applicable
Recruiting
Conditions
Glucocorticoid-induced osteoporosis
Registration Number
JPRN-UMIN000019642
Lead Sponsor
Gifu University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Medicine associated with the bone metabolism Pregnancy Abnormality of the serum calcium Less than 30ml/min/1.73m2 of the eGFR Severe complications such as liver, heart, renal disease Hypersentivity

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath